Collaborative Neuroscience Network, Inc.

Long Beach, California 90808

0 studies enrolling now · 20 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Crohn's Disease, Diarrhea Predominant Irritable Bowel Syndrome, Dyslipidemia, Epilepsies, Partial, Hypercholesterolemia, Low Back Pain, Migraine, Migraine Headache, Multiple Sclerosis, Pain

Studies at this site

• Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition — Completed
• Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Once-A-Day Pregabalin For Partial Seizures — Completed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
• A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). — Stopped early
• A Study of LY2951742 in Participants With Migraine — Completed
• A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins — Completed
• Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo — Completed
• Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain — Completed
• Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) — Completed
• Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients — Stopped early
• Safety, Efficacy and Pharmacokinetics of ALD403 — Completed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease — Stopped early
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis — Completed